Heart Valves pp 227-260 | Cite as

Transcatheter Aortic Valve Implantation

Chapter

Abstract

The first-in-human transcatheter aortic valve implantation (TAVI) was successfully performed in 2002. In excess of 50,000 TAVI procedures have been performed to date using the Edwards SAPIEN or Medtronic CoreValve transcatheter aortic valves. In this chapter, a brief overview of patient selection criteria, descriptions of the Edwards SAPIEN and Medtronic CoreValve systems, and the procedural techniques for transfemoral TAVI will be provided. Additionally, the cardiac and non-cardiac complications associated with TAVI will be discussed and the available TAVI literature will be summarized.

Keywords

Titanium Nickel Catheter Creatinine Polyethylene 

Abbreviations

MRI

Magnetic resonance imaging

MSCT

Multi-slice CT

PARTNER trial

Placement of AoRTic TraNscathetER Valve

SFAR ratio

Outer Sheath diameter to Femoral Artery minimal luminal diameter Ratio

STS

Society of thoracic surgeons

TAVI

Transcatheter aortic valve implantation

TEE

Transesophageal echocardiography

TTE

Transthoracic echocardiography

VARC

Valvular academic research consortium

References

  1. 1.
    Davies H (1965) Catheter-mounted valve for temporary relief of aortic insufficiency. Lancet 285:250CrossRefGoogle Scholar
  2. 2.
    Moulopoulos SD, Anthopoulos L, Stamatelopoulos S et al (1971) Catheter-mounted aortic valves. Ann Thorac Surg 11:423–430PubMedCrossRefGoogle Scholar
  3. 3.
    Phillips SJ, Ciborski M, Freed PS et al (1976) A temporary catheter-tip aortic valve: hemodynamic effects on experimental acute aortic insufficiency. Ann Thorac Surg 21:134–137PubMedCrossRefGoogle Scholar
  4. 4.
    Matsubara T, Yamazoe M, Tamura Y et al (1992) Balloon catheter with check valves for experimental relief of acute aortic regurgitation. Am Heart J 124:1002–1008PubMedCrossRefGoogle Scholar
  5. 5.
    Cribier A, Savin T, Saoudi N et al (1986) Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet 1:63–67PubMedCrossRefGoogle Scholar
  6. 6.
    Drobinski G, Lechat P, Metzger JP et al (1987) Results of percutaneous catheter valvuloplasty for calcified aortic stenosis in the elderly. Eur Heart J 8:322–328PubMedGoogle Scholar
  7. 7.
    Serruys PW, Luijten HE, Beatt KJ et al (1988) Percutaneous balloon valvuloplasty for calcific aortic stenosis. A treatment ‘sine cure’? Eur Heart J 9:782–794PubMedCrossRefGoogle Scholar
  8. 8.
    Safian RD, Berman AD, Diver DJ et al (1988) Balloon aortic valvuloplasty in 170 consecutive patients. N Engl J Med 319:125–130PubMedCrossRefGoogle Scholar
  9. 9.
    Block PC, Palacios IF (1988) Clinical and hemodynamic follow-up after percutaneous aortic valvuloplasty in the elderly. Am J Cardiol 62:760–763PubMedCrossRefGoogle Scholar
  10. 10.
    Berland J, Cribier A, Savin T et al (1989) Percutaneous balloon valvuloplasty in patients with severe aortic stenosis and low ejection fraction. Immediate results and 1-year follow-up. Circulation 79:1189–1196PubMedCrossRefGoogle Scholar
  11. 11.
    Letac B, Cribier A, Eltchaninoff H et al (1991) Evaluation of restenosis after balloon dilatation in adult aortic stenosis by repeat catheterization. Am Heart J 122:55–60PubMedCrossRefGoogle Scholar
  12. 12.
    Otto CM, Mickel MC, Kennedy JW et al (1994) Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 89:642–650PubMedCrossRefGoogle Scholar
  13. 13.
    Charlson E, Legedza AT, Hamel MB (2006) Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 15:312–321PubMedGoogle Scholar
  14. 14.
    Pellikka PA, Sarano ME, Nishimura RA et al (2005) Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 111:3290–3295PubMedCrossRefGoogle Scholar
  15. 15.
    Iung B, Cachier A, Baron G et al (2005) Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 26:2714–2720PubMedCrossRefGoogle Scholar
  16. 16.
    Bouma BJ, van Den Brink RB, van Der Meulen JH et al (1999) To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 82:143–148PubMedGoogle Scholar
  17. 17.
    Cribier A, Eltchaninoff H, Bash A et al (2002) Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106:3006–3008PubMedCrossRefGoogle Scholar
  18. 18.
    Cribier A, Eltchaninoff H, Tron C et al (2006) Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 47:1214–1223PubMedCrossRefGoogle Scholar
  19. 19.
    Webb JG, Chandavimol M, Thompson CR et al (2006) Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113:842–850PubMedCrossRefGoogle Scholar
  20. 20.
    Hijazi Z, Ruiz C, Bonhoeffer P et al (2006) Transcatheter valve repair, 1st edn. Informa Healthcare, Taylor & Francis, New YorkGoogle Scholar
  21. 21.
    de Jaegere P, van Dijk L, Laborde JC et al (2007) True percutaneous implantation of the CoreValve aortic valve prosthesis by the combined use of ultrasound guided vascular access, Prostar XL and the TandemHeart. EuroIntervention 2:500–505PubMedGoogle Scholar
  22. 22.
    O’Brien SM, Shahian DM, Filardo G et al (2009) The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg 88:S23–S42PubMedCrossRefGoogle Scholar
  23. 23.
    Kuduvalli M, Grayson AD, Au J et al (2007) A multi-centre additive and logistic risk model for in-hospital mortality following aortic valve replacement. Eur J Cardiothorac Surg 31:607–613PubMedCrossRefGoogle Scholar
  24. 24.
    Hannan EL, Wu C, Bennett EV et al (2007) Risk index for predicting in-hospital mortality for cardiac valve surgery. Ann Thorac Surg 83:921–929PubMedCrossRefGoogle Scholar
  25. 25.
    Rankin JS, Hammill BG, Ferguson TB Jr et al (2006) Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg 131:547–557PubMedCrossRefGoogle Scholar
  26. 26.
    Nilsson J, Algotsson L, Hoglund P et al (2006) Comparison of 19 pre-operative risk stratification models in open-heart surgery. Eur Heart J 27:867–874PubMedCrossRefGoogle Scholar
  27. 27.
    Jin R, Grunkemeier GL, Starr A (2005) Validation and refinement of mortality risk models for heart valve surgery. Ann Thorac Surg 80:471–479PubMedCrossRefGoogle Scholar
  28. 28.
    Ambler G, Omar RZ, Royston P et al (2005) Generic, simple risk stratification model for heart valve surgery. Circulation 112:224–231PubMedCrossRefGoogle Scholar
  29. 29.
    Nowicki ER, Birkmeyer NJ, Weintraub RW et al (2004) Multivariable prediction of in-hospital mortality associated with aortic and mitral valve surgery in Northern New England. Ann Thorac Surg 77:1966–1977PubMedCrossRefGoogle Scholar
  30. 30.
    Gardner SC, Grunwald GK, Rumsfeld JS et al (2004) Comparison of short-term mortality risk factors for valve replacement versus coronary artery bypass graft surgery. Ann Thorac Surg 77:549–556PubMedCrossRefGoogle Scholar
  31. 31.
    Florath I, Rosendahl UP, Mortasawi A et al (2003) Current determinants of operative mortality in 1400 patients requiring aortic valve replacement. Ann Thorac Surg 76:75–83PubMedCrossRefGoogle Scholar
  32. 32.
    Edwards FH, Peterson ED, Coombs LP et al (2001) Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol 37:885–892PubMedCrossRefGoogle Scholar
  33. 33.
    Nashef SA, Roques F, Michel P et al (1999) European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9–13PubMedCrossRefGoogle Scholar
  34. 34.
    Parsonnet V, Dean D, Bernstein AD (1989) A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 79:I3–I12PubMedGoogle Scholar
  35. 35.
    Osswald BR, Gegouskov V, Badowski-Zyla D et al (2009) Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement. Eur Heart J 30:74–80PubMedCrossRefGoogle Scholar
  36. 36.
    Leontyev S, Walther T, Borger MA et al (2009) Aortic valve replacement in octogenarians: utility of risk stratification with EuroSCORE. Ann Thorac Surg 87:1440–1445PubMedCrossRefGoogle Scholar
  37. 37.
    Dewey TM, Brown D, Ryan WH et al (2008) Reliability of risk algorithms in predicting early and late operative outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 135:180–187PubMedCrossRefGoogle Scholar
  38. 38.
    Brown ML, Schaff HV, Sarano ME et al (2008) Is the European System for Cardiac Operative Risk evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg 136:566–571PubMedCrossRefGoogle Scholar
  39. 39.
    Lefevre T, Kappetein AP, Wolner E et al (2011) One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 32:148–157PubMedCrossRefGoogle Scholar
  40. 40.
    Buellesfeld L, Gerckens U, Schuler G et al (2011) 2-year follow-up of patients undergoing transcatheter aortic valve implantation using a self-expanding valve prosthesis. J Am Coll Cardiol 57:1650–1657PubMedCrossRefGoogle Scholar
  41. 41.
    Piazza N, Wenaweser P, van Gameren M et al (2010) Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system—a Bern-Rotterdam Study. Am Heart J 159:323–329PubMedCrossRefGoogle Scholar
  42. 42.
    Delgado V, Ewe SH, Ng AC et al (2010) Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility. EuroIntervention 6:643–652PubMedCrossRefGoogle Scholar
  43. 43.
    Piazza N, de Jaegere P, Manoharan G et al (2011) Patient selection for the CoreValve ReValving System. In: Serruys P, Piazza N, Cribier A, Webb J, Laborde JC, de Jaegere P (eds) Transcatheter aortic valve implantation: tips and tricks to avoid failure. Informa Healthcare, New York, p 82Google Scholar
  44. 44.
    Nietlispach F, Leipsic J, Al-Bugami S et al (2009) CT of the ilio-femoral arteries using direct aortic contrast injection: proof of feasibility in patients screened towards percutaneous aortic valve replacement. Swiss Med Wkly 139:458–462PubMedGoogle Scholar
  45. 45.
    Eltchaninoff H, Kerkeni M, Zajarias A et al (2009) Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesis. EuroIntervention 5:438–442PubMedCrossRefGoogle Scholar
  46. 46.
    Hayashida K, Lefevre T, Chevalier B et al (2011) Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 4:851–858PubMedCrossRefGoogle Scholar
  47. 47.
    Piazza N, Serruys PW, Lange R (2011) Getting safely in and out of a transcatheter aortic valve implantation procedure vascular complications according to the valvular academic research consortium criteria. JACC Cardiovasc Interv 4:859–860PubMedCrossRefGoogle Scholar
  48. 48.
    Piazza N, de Jaegere P, Schultz C et al (2008) Anatomy of the aortic valvar complex and its implications for transcatheter implantation of the aortic valve. Circ Cardiovasc Interv 1:74–81PubMedCrossRefGoogle Scholar
  49. 49.
    Schultz CJ, Moelker A, Piazza N et al (2010) Three dimensional evaluation of the aortic annulus using multislice computer tomography: are manufacturer’s guidelines for sizing for percutaneous aortic valve replacement helpful? Eur Heart J 31:849–856PubMedCrossRefGoogle Scholar
  50. 50.
    Tops LF, Wood DA, Delgado V et al (2008) Noninvasive evaluation of the aortic root with multislice computed tomography implications for transcatheter aortic valve replacement. JACC Cardiovasc Imaging 1:321–330PubMedCrossRefGoogle Scholar
  51. 51.
    Ng AC, Yiu KH, Ewe SH et al (2011) Influence of left ventricular geometry and function on aortic annular dimensions as assessed with multi-detector row computed tomography: implications for transcatheter aortic valve implantation. Eur Heart J 32:2806–2813PubMedCrossRefGoogle Scholar
  52. 52.
    Schultz C, Moelker A, Tzikas A et al (2010) The use of MSCT for the evaluation of the aortic root before transcutaneous aortic valve implantation: the Rotterdam approach. EuroIntervention 6:505–511PubMedCrossRefGoogle Scholar
  53. 53.
    Schultz CJ, Moelker AD, Tzikas A et al (2010) Cardiac CT: necessary for precise sizing for transcatheter aortic implantation. EuroIntervention 6(suppl G):G6–G13PubMedGoogle Scholar
  54. 54.
    Nietlispach F, Wijesinghe N, Wood D et al (2010) Current balloon-expandable transcatheter heart valve and delivery systems. Catheter Cardiovasc Interv 75:295–300PubMedCrossRefGoogle Scholar
  55. 55.
    Rodes-Cabau J, Delarochelliere R, Dumont E (2012) First-in-man transcatheter aortic valve implantation of a 20-mm Edwards SAPIEN XT valve: one step forward for the treatment of patients with severe aortic stenosis and small aortic annulus. Catheter Cardiovasc Interv 79:789–793PubMedCrossRefGoogle Scholar
  56. 56.
    Chen W, Schoen FJ, Levy RJ (1994) Mechanism of efficacy of 2-amino oleic acid for inhibition of calcification of glutaraldehyde-pretreated porcine bioprosthetic heart valves. Circulation 90:323–329PubMedCrossRefGoogle Scholar
  57. 57.
    Petronio AS, De Carlo M, Bedogni F et al (2010) Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 3:359–366PubMedCrossRefGoogle Scholar
  58. 58.
    Vavuranakis M, Vrachatis DA, Filis K et al (2011) Trans-catheter aortic-valve implantation by the subclavian approach complicated with vessel dissection and transient left-arm paralysis. Eur J Cardiothorac Surg 39:127–129PubMedCrossRefGoogle Scholar
  59. 59.
    Fraccaro C, Napodano M, Tarantini G et al (2009) Expanding the eligibility for transcatheter aortic valve implantation the trans-subclavian retrograde approach using: the III generation CoreValve revalving system. JACC Cardiovasc Interv 2:828–833PubMedCrossRefGoogle Scholar
  60. 60.
    Bruschi G, Fratto P, De Marco F et al (2010) The trans-subclavian retrograde approach for transcatheter aortic valve replacement: single-center experience. J Thorac Cardiovasc Surg 140:911–915PubMedCrossRefGoogle Scholar
  61. 61.
    De Marco F, Bruschi G, Klugmann S (2011) Transcatheter aortic valve implantation by left subclavian access in the presence of a patent LIMA to LAD graft. Catheter Cardiovasc Interv 77:430–434PubMedCrossRefGoogle Scholar
  62. 62.
    Modine T, Obadia JF, Choukroun E et al (2011) Transcutaneous aortic valve implantation using the axillary/subclavian access: feasibility and early clinical outcomes. J Thorac Cardiovasc Surg 141:487–491PubMedCrossRefGoogle Scholar
  63. 63.
    Vavuranakis M, Vrachatis DA, Toutouzas K et al (2010) Successful percutaneous aortic valve implantation via a stenotic left subclavian artery access. Heart Vessels 25:359–362PubMedCrossRefGoogle Scholar
  64. 64.
    Munoz-Garcia AJ, Alonso-Briales JH, Such-Martinez M et al (2010) Left subclavian artery approach to CoreValve aortic prosthesis implantation. Rev Esp Cardiol 63:121–122PubMedCrossRefGoogle Scholar
  65. 65.
    Ruge H, Lange R, Bleiziffer S et al (2008) First successful aortic valve implantation with the CoreValve ReValving System via right subclavian artery access: a case report. Heart Surg Forum 11:E323–E324PubMedCrossRefGoogle Scholar
  66. 66.
    Bauernschmitt R, Schreiber C, Bleiziffer S et al (2009) Transcatheter aortic valve implantation through the ascending aorta: an alternative option for no-access patients. Heart Surg Forum 12:E63–E64PubMedCrossRefGoogle Scholar
  67. 67.
    Bruschi G, De Marco F, Fratto P et al (2011) Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valves implantation: single-center experience. Eur J Cardiothorac Surg 39:e151–e158PubMedCrossRefGoogle Scholar
  68. 68.
    Latsios G, Gerckens U, Grube E (2010) Transaortic transcatheter aortic valve implantation: a novel approach for the truly “no-access option” patients. Catheter Cardiovasc Interv 75:1129–1136PubMedGoogle Scholar
  69. 69.
    Cockburn J, Trivedi U, Hildick-Smith D (2011) Transaortic transcatheter aortic valve implantation within a previous bioprosthetic aortic valve replacement. Catheter Cardiovasc Interv 78:479–484PubMedGoogle Scholar
  70. 70.
    Sarkar K, Ussia GP, Tamburino C (2011) Transcatheter aortic valve implantation for severe aortic regurgitation in a stentless bioprosthetic valve with the core valve revalving system-technical tips and role of the Accutrak system. Catheter Cardiovasc Interv 78:485–490PubMedCrossRefGoogle Scholar
  71. 71.
    de Jaegere P, Piazza N, Tzikas A et al (2011) Implantation of the CoreValve ReValving System. In: Serruys P, Piazza N, Cribier A, Webb J, Laborde J, de Jaegere P (eds) Transcatheter aortic valve: tips and tricks to avoid failure, 1st edn. Informa Healthcare, New York, pp 183–197Google Scholar
  72. 72.
    Nietlispach F, Webb J (2011) Implantation of the Edwards SAPIEN valve. In: Serruys P, Piazza N, Cribier A, Webb J, Laborde J, de Jaegere P (eds) Transcatheter aortic valve implantation, 1st edn. Informa Healthcare, New York, pp 198–206Google Scholar
  73. 73.
    Hutchinson N (2011) Sedation vs general anaesthesia for the ‘high-risk’ patient—what can TAVI teach us? Anaesthesia 66:965–968PubMedCrossRefGoogle Scholar
  74. 74.
    Motloch LJ, Rottlaender D, Reda S et al (2011) Local versus general anesthesia for transfemoral aortic valve implantation. Clin Res Cardiol 101:45–53PubMedCrossRefGoogle Scholar
  75. 75.
    Dehedin B, Guinot PG, Ibrahim H et al (2011) Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of general versus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth 25:1036–1043PubMedCrossRefGoogle Scholar
  76. 76.
    Covello RD, Landoni G, Zangrillo A (2011) Anesthetic management of transcatheter aortic valve implantation. Curr Opin Anaesthesiol 24:417–425PubMedCrossRefGoogle Scholar
  77. 77.
    Guinot PG, Depoix JP, Tini L et al (2011) Transcutaneous aortic valve implantation: anesthetic and perioperative management. Ann Fr Anesth Reanim 30:734–742PubMedCrossRefGoogle Scholar
  78. 78.
    Vavuranakis M, Voudris V, Vrachatis DA et al (2010) Transcatheter aortic valve implantation, patient selection process and procedure: two centres’ experience of the intervention without general anaesthesia. Hellenic J Cardiol 51:492–500PubMedGoogle Scholar
  79. 79.
    Guinot PG, Depoix JP, Etchegoyen L et al (2010) Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 24:752–761PubMedCrossRefGoogle Scholar
  80. 80.
    Covello RD, Ruggeri L, Landoni G et al (2010) Transcatheter implantation of an aortic valve: anesthesiological management. Minerva Anestesiol 76:100–108PubMedGoogle Scholar
  81. 81.
    Behan M, Haworth P, Hutchinson N et al (2008) Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv 72:1012–1015PubMedCrossRefGoogle Scholar
  82. 82.
    Bergmann L, Kahlert P, Eggebrecht H et al (2011) Transfemoral aortic valve implantation under sedation and monitored anaesthetic care—a feasibility study. Anaesthesia 66:977–982PubMedCrossRefGoogle Scholar
  83. 83.
    Fassl J, Walther T, Groesdonk HV et al (2009) Anesthesia management for transapical transcatheter aortic valve implantation: a case series. J Cardiothorac Vasc Anesth 23:286–291PubMedCrossRefGoogle Scholar
  84. 84.
    Wood DA, Tops LF, Mayo JR et al (2009) Role of multislice computed tomography in transcatheter aortic valve replacement. Am J Cardiol 103:1295–1301PubMedCrossRefGoogle Scholar
  85. 85.
    Tzikas A, Schultz C, Van Mieghem NM et al (2010) Optimal projection estimation for transcatheter aortic valve implantation based on contrast-aortography: validation of a Prototype Software. Catheter Cardiovasc Interv 76:602–607PubMedCrossRefGoogle Scholar
  86. 86.
    Dvir D, Kornowski R (2010) Percutaneous aortic valve implantation using novel imaging guidance. Catheter Cardiovasc Interv 76:450–454PubMedCrossRefGoogle Scholar
  87. 87.
    Kurra V, Kapadia SR, Tuzcu EM et al (2010) Pre-procedural imaging of aortic root orientation and dimensions: comparison between X-ray angiographic planar imaging and 3-dimensional multidetector row computed tomography. JACC Cardiovasc Interv 3:105–113PubMedCrossRefGoogle Scholar
  88. 88.
    Cockburn J, de Belder A, Brooks M et al (2011) Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the prostar system in 118 cases. Catheter Cardiovasc Interv 79:143–149PubMedCrossRefGoogle Scholar
  89. 89.
    Sharp AS, Michev I, Maisano F et al (2010) A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 75:784–793PubMedCrossRefGoogle Scholar
  90. 90.
    Nuis RJ, Piazza N, Van Mieghem NM et al (2011) In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 78:457–467PubMedGoogle Scholar
  91. 91.
    Conradi L, Seiffert M, Treede H et al (2011) Transcatheter aortic valve implantation versus surgical aortic valve replacement: a propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg 143:64–71PubMedCrossRefGoogle Scholar
  92. 92.
    Clavel MA, Webb JG, Pibarot P et al (2009) Comparison of the hemodynamic performance of percutaneous and surgical bioprostheses for the treatment of severe aortic stenosis. J Am Coll Cardiol 53:1883–1891PubMedCrossRefGoogle Scholar
  93. 93.
    Himbert D, Descoutures F, Al-Attar N et al (2009) Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 54:303–311PubMedCrossRefGoogle Scholar
  94. 94.
    Jilaihawi H, Chin D, Spyt T et al (2010) Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic-CoreValve bioprosthesis. Eur Heart J 31:857–864PubMedCrossRefGoogle Scholar
  95. 95.
    Moss RR, Ivens E, Pasupati S et al (2008) Role of echocardiography in percutaneous aortic valve implantation. JACC Cardiovasc Imaging 1:15–24PubMedCrossRefGoogle Scholar
  96. 96.
    Jabbour A, Ismail TF, Moat N et al (2011) Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol 58:2165–2173PubMedCrossRefGoogle Scholar
  97. 97.
    Detaint D, Lepage L, Himbert D et al (2009) Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence. JACC Cardiovasc Interv 2:821–827PubMedCrossRefGoogle Scholar
  98. 98.
    Moat NE, Ludman P, de Belder MA et al (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 58:2130–2138PubMedCrossRefGoogle Scholar
  99. 99.
    Schultz C, Rossi A, van Mieghem N et al (2011) Aortic annulus dimensions and leaflet calcification from contrast MSCT predict the need for balloon post-dilatation after TAVI with the Medtronic CoreValve prosthesis. EuroIntervention 7:564–572PubMedCrossRefGoogle Scholar
  100. 100.
    Ong SH, Mueller R, Gerckens U (2011) Sequential CoreValve implantation for a mal-positioned prosthesis during transcatheter aortic valve implantation. Catheter Cardiovasc Interv 77:1071–1075PubMedCrossRefGoogle Scholar
  101. 101.
    Zahn R, Schiele R, Kilkowski C et al (2011) Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValveTM prosthesis due to a too-low implantation, using transcatheter repositioning. J Heart Valve Dis 20:64–69PubMedGoogle Scholar
  102. 102.
    Litzler PY, Cribier A, Zajarias A et al (2008) Surgical aortic valve replacement after percutaneous aortic valve implantation: what have we learned? J Thorac Cardiovasc Surg 136:697–701PubMedCrossRefGoogle Scholar
  103. 103.
    Al-Attar N, Ghodbane W, Himbert D et al (2009) Unexpected complications of transapical aortic valve implantation. Ann Thorac Surg 88:90–94PubMedCrossRefGoogle Scholar
  104. 104.
    Takagi K, Latib A, Al-Lamee R et al (2011) Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 78:432–443PubMedGoogle Scholar
  105. 105.
    Al-Attar N, Himbert D, Vahanian A et al (2011) Severe intraprosthetic regurgitation by immobile leaflet after trans-catheter aortic valve implantation. Eur J Cardiothorac Surg 39:591–592PubMedCrossRefGoogle Scholar
  106. 106.
    Zahn R, Schiele R, Kilkowski C et al (2010) Severe aortic regurgitation after percutaneous transcatheter aortic valve implantation: on the importance to clarify the underlying pathophysiology. Clin Res Cardiol 99:193–197PubMedCrossRefGoogle Scholar
  107. 107.
    Miranda-Balbuena N, Araji OA, Gutierrez-Martin MA et al (2011) Management of aortic valve dysfunction after transapical approach using the technique “valve after valve”. Ann Thorac Surg 92:1102–1104PubMedCrossRefGoogle Scholar
  108. 108.
    Clavel MA, Dumont E, Pibarot P et al (2009) Severe valvular regurgitation and late prosthesis embolization after percutaneous aortic valve implantation. Ann Thorac Surg 87:618–621PubMedCrossRefGoogle Scholar
  109. 109.
    Baumbach H, Hill S, Hansen M et al (2011) Severe aortic insufficiency after transapical aortic valve implantation. Ann Thorac Surg 92:728–729PubMedCrossRefGoogle Scholar
  110. 110.
    Pagnotta P, Ferrante G, Presbitero P (2011) Rescue “valve in valve” implantation after late onset CoreValve cusp rupture leading to acute massive aortic insufficiency. Catheter Cardiovasc Interv. doi: 10.1002/ccd.23155 [Epub ahead of print]
  111. 111.
    Leon MB, Piazza N, Nikolsky E et al (2011) Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J 32:205–217PubMedCrossRefGoogle Scholar
  112. 112.
    Leon MB, Piazza N, Nikolsky E et al (2011) Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol 57:253–269PubMedCrossRefGoogle Scholar
  113. 113.
    Igawa O, Adachi M, Yano A et al (2009) Anatomical information for catheter ablation concerning the relationship between the aortic non-coronary cusp and the His-bundle. Circ J 257:73Google Scholar
  114. 114.
    Aktug O, Dohmen G, Brehmer K et al (2012) Incidence and predictors of left bundle branch block after transcatheter aortic valve implantation. Int J Cardiol 160:26–30PubMedCrossRefGoogle Scholar
  115. 115.
    Baan J Jr, Yong ZY, Koch KT et al (2010) Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J 159:497–503PubMedCrossRefGoogle Scholar
  116. 116.
    Bleiziffer S, Ruge H, Horer J et al (2010) Predictors for new-onset complete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:524–530PubMedCrossRefGoogle Scholar
  117. 117.
    Calvi V, Puzzangara E, Pruiti GP et al (2009) Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 32(suppl 1):S126–S130PubMedCrossRefGoogle Scholar
  118. 118.
    Erkapic D, Kim WK, Weber M et al (2010) Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace 12:1188–1190PubMedCrossRefGoogle Scholar
  119. 119.
    Ferreira ND, Caeiro D, Adao L et al (2010) Incidence and predictors of permanent pacemaker requirement after transcatheter aortic valve implantation with a self-expanding bioprosthesis. Pacing Clin Electrophysiol 33:1364–1372PubMedCrossRefGoogle Scholar
  120. 120.
    Fraccaro C, Buja G, Tarantini G et al (2011) Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 107:747–754PubMedCrossRefGoogle Scholar
  121. 121.
    Guetta V, Goldenberg G, Segev A et al (2011) Predictors and course of high-degree atrioventricular block after transcatheter aortic valve implantation using the CoreValve Revalving system. Am J Cardiol 108:1600–1605PubMedCrossRefGoogle Scholar
  122. 122.
    Haworth P, Behan M, Khawaja M et al (2010) Predictors for permanent pacing after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 76:751–756PubMedCrossRefGoogle Scholar
  123. 123.
    Khawaja MZ, Rajani R, Cook A et al (2011) Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation 123:951–960PubMedCrossRefGoogle Scholar
  124. 124.
    Koos R, Mahnken AH, Aktug O et al (2011) Electrocardiographic and imaging predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. J Heart Valve Dis 20:83–90PubMedGoogle Scholar
  125. 125.
    Latsios G, Gerckens U, Buellesfeld L et al (2010) “Device landing zone” calcification, assessed by MSCT, as a predictive factor for pacemaker implantation after TAVI. Catheter Cardiovasc Interv 76:431–439PubMedCrossRefGoogle Scholar
  126. 126.
    Nuis RJ, Van Mieghem NM, Schultz CJ et al (2011) Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J 32:2067–2074PubMedCrossRefGoogle Scholar
  127. 127.
    Piazza N, Nuis RJ, Tzikas A et al (2010) Persistent conduction abnormalities and requirements for pacemaking six months after transcatheter aortic valve implantation. EuroIntervention 6:475–484PubMedCrossRefGoogle Scholar
  128. 128.
    Piazza N, Onuma Y, Jesserun E et al (2008) Early and persistent intraventricular conduction abnormalities and requirements for pacemaking after percutaneous replacement of the aortic valve. J Am Coll Cardiol Interv 1:310–316Google Scholar
  129. 129.
    Roten L, Wenaweser P, Delacretaz E et al (2010) Incidence and predictors of atrioventricular conduction impairment after transcatheter aortic valve implantation. Am J Cardiol 106:1473–1480PubMedCrossRefGoogle Scholar
  130. 130.
    Rubin JM, Avanzas P, del Valle R et al (2011) Atrioventricular conduction disturbance characterization in transcatheter aortic valve implantation with the CoreValve prosthesis. Circ Cardiovasc Interv 4:280–286PubMedCrossRefGoogle Scholar
  131. 131.
    Jilaihawi H, Chin D, Vasa-Nicotera M et al (2009) Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 157:860–866PubMedCrossRefGoogle Scholar
  132. 132.
    Godin M, Eltchaninoff H, Furuta A et al (2010) Frequency of conduction disturbances after transcatheter implantation of an Edwards Sapien aortic valve prosthesis. Am J Cardiol 106:707–712PubMedCrossRefGoogle Scholar
  133. 133.
    Gutierrez M, Rodes-Cabau J, Bagur R et al (2009) Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 158:302–308PubMedCrossRefGoogle Scholar
  134. 134.
    Sinhal A, Altwegg A, Pasupati S et al (2008) Atrioventricular block after transcatheter balloon expandable aortic valve implantation. J Am Coll Cardiol Interv 1:305–309Google Scholar
  135. 135.
    Koektuerk B, Schaefer U, Bergmann M et al (2009) Acquired conduction disturbances after percutaneous aortic valve replacement. Circulation 120:S307Google Scholar
  136. 136.
    Saia F, Lemos PA, Bordoni B et al (2011) Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. Catheter Cardiovasc Interv 79:712–719CrossRefGoogle Scholar
  137. 137.
    Epstein AE, DiMarco JP, Ellenbogen KA et al (2008) ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 51:e1–e62PubMedCrossRefGoogle Scholar
  138. 138.
    Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Europace 9:959–998PubMedCrossRefGoogle Scholar
  139. 139.
    Fiorina C, Curello S, Maffeo D et al (2012) Management of acute left main obstruction after transcatheter aortic valve replacement: the “tunnel technique”. Cardiovasc Revasc Med 13:142.e5–142.e9CrossRefGoogle Scholar
  140. 140.
    Gurvitch R, Cheung A, Bedogni F et al (2011) Coronary obstruction following transcatheter aortic valve-in-valve implantation for failed surgical bioprostheses. Catheter Cardiovasc Interv 77:439–444PubMedCrossRefGoogle Scholar
  141. 141.
    Kapadia SR, Svensson L, Tuzcu EM (2009) Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv 73:966–972PubMedCrossRefGoogle Scholar
  142. 142.
    Kukucka M, Pasic M, Dreysse S et al (2011) Delayed subtotal coronary obstruction after transapical aortic valve implantation. Interact Cardiovasc Thorac Surg 12:57–60PubMedCrossRefGoogle Scholar
  143. 143.
    Webb JG (2009) Coronary obstruction due to transcatheter valve implantation. Catheter Cardiovasc Interv 73:973PubMedCrossRefGoogle Scholar
  144. 144.
    Gogas BD, Zacharoulis AA, Antoniadis AG (2011) Acute coronary occlusion following TAVI. Catheter Cardiovasc Interv 77:435–438PubMedCrossRefGoogle Scholar
  145. 145.
    Saia F, Marrozzini C, Marzocchi A (2011) Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. J Invasive Cardiol 23:E106–E109PubMedGoogle Scholar
  146. 146.
    Gerckens U, Latsios G, Mueller R et al (2009) Left main PCI after trans-subclavian CoreValve implantation. Successful outcome of a combined procedure for management of a rare complication. Clin Res Cardiol 98:687–690PubMedCrossRefGoogle Scholar
  147. 147.
    Bagur R, Dumont E, Doyle D et al (2010) Coronary ostia stenosis after transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:253–255PubMedCrossRefGoogle Scholar
  148. 148.
    Bartorelli AL, Andreini D, Sisillo E et al (2010) Left main coronary artery occlusion after percutaneous aortic valve implantation. Ann Thorac Surg 89:953–955PubMedCrossRefGoogle Scholar
  149. 149.
    Stabile E, Sorropago G, Cioppa A et al (2010) Acute left main obstructions following TAVI. EuroIntervention 6:100–105PubMedCrossRefGoogle Scholar
  150. 150.
    Piazza N, Grube E, Gerckens U et al (2008) Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 F) CoreValve ReValving System: results from the multicenter, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4:242–249PubMedCrossRefGoogle Scholar
  151. 151.
    Lange R, Bleiziffer S, Piazza N et al (2011) Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg 40:1105–1113PubMedGoogle Scholar
  152. 152.
    Webb JG, Pasupati S, Humphries K et al (2007) Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116:755–763PubMedCrossRefGoogle Scholar
  153. 153.
    Ong SH, Mueller R, Iversen S (2012) Early calcific degeneration of a CoreValve transcatheter aortic bioprosthesis. Eur Heart J 33:586PubMedCrossRefGoogle Scholar
  154. 154.
    Hammerstingl C, Nickenig G, Grube E (2011) Treatment of a degenerative stenosed CoreValve aortic bioprosthesis by transcatheter valve-in-valve insertion. Catheter Cardiovasc Interv 79:748–755PubMedCrossRefGoogle Scholar
  155. 155.
    Virmani R, Bonan R, Nakazawa G et al (2011) Accumulation of worldwide experience with postmortem studies of transcatheter aortic valve implantation: what should we be avoiding? In: Serruys P, Piazza N, Cribier A, Webb J, Laborde J (eds) Transcatheter aortic valve implantation: tips and tricks to avoid failure. Informa Healthcare, New York, pp 18–39Google Scholar
  156. 156.
    Tay EL, Gurvitch R, Wijeysinghe N et al (2011) Valve thrombosis after transcatheter heart valve implantation. EuroIntervention 7:170–171PubMedCrossRefGoogle Scholar
  157. 157.
    Kefer J, Astarci P, Renkin J et al (2010) Images and case reports in interventional cardiology. Thrombotic aortic restenosis after transapical Sapien valve implantation. Circ Cardiovasc Interv 3:289–292PubMedCrossRefGoogle Scholar
  158. 158.
    Trepels T, Martens S, Doss M et al (2009) Images in cardiovascular medicine. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 120:e23–e24PubMedCrossRefGoogle Scholar
  159. 159.
    Smith CR, Leon MB, Mack MJ et al (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198PubMedCrossRefGoogle Scholar
  160. 160.
    Ussia GP, Scarabelli M, Mule M et al (2011) Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 108:1772–1776PubMedCrossRefGoogle Scholar
  161. 161.
    Head SJ, Dewey TM, Mack MJ (2011) Fungal endocarditis after transfemoral aortic valve implantation. Catheter Cardiovasc Interv 78:1017–1019PubMedCrossRefGoogle Scholar
  162. 162.
    Carnero-Alcazar M, Maroto Castellanos LC, Carnicer JC et al (2010) Transapical aortic valve prosthetic endocarditis. Interact Cardiovasc Thorac Surg 11:252–253PubMedCrossRefGoogle Scholar
  163. 163.
    Gotzmann M, Mugge A (2011) Fatal prosthetic valve endocarditis of the CoreValve ReValving System. Clin Res Cardiol 100:715–717PubMedCrossRefGoogle Scholar
  164. 164.
    Santos M, Thiene G, Sievers HH et al (2011) Candida endocarditis complicating transapical aortic valve implantation. Eur Heart J 32:2265PubMedCrossRefGoogle Scholar
  165. 165.
    Comoglio C, Boffini M, El Qarra S et al (2009) Aortic valve replacement and mitral valve repair as treatment of complications after percutaneous core valve implantation. J Thorac Cardiovasc Surg 138:1025–1027PubMedCrossRefGoogle Scholar
  166. 166.
    Wong DR, Boone RH, Thompson CR et al (2009) Mitral valve injury late after transcatheter aortic valve implantation. J Thorac Cardiovasc Surg 137:1547–1549PubMedCrossRefGoogle Scholar
  167. 167.
    Rafiq I, Parthasarathy H, Tremlett C et al (2011) Infective endocarditis caused by Moraxella nonliquefaciens in a percutaneous aortic valve replacement. Cardiovasc Revasc Med 12:184–186PubMedCrossRefGoogle Scholar
  168. 168.
    Tzikas A, Piazza N, van Dalen BM et al (2010) Changes in mitral regurgitation after transcatheter aortic valve implantation. Catheter Cardiovasc Interv 75:43–49PubMedCrossRefGoogle Scholar
  169. 169.
    De Chiara B, Moreo A, De Marco F et al (2011) Influence of CoreValve ReValving System implantation on mitral valve function: an echocardiographic study in selected patients. Catheter Cardiovasc Interv 78:638–644PubMedCrossRefGoogle Scholar
  170. 170.
    Durst R, Avelar E, McCarty D et al (2011) Outcome and improvement predictors of mitral regurgitation after transcatheter aortic valve implantation. J Heart Valve Dis 20:272–281PubMedGoogle Scholar
  171. 171.
    Hekimian G, Detaint D, Messika-Zeitoun D et al (2012) Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr 25:160–165PubMedCrossRefGoogle Scholar
  172. 172.
    Webb JG, Altwegg L, Boone RH et al (2009) Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119:3009–3016PubMedCrossRefGoogle Scholar
  173. 173.
    Rodes-Cabau J, Webb JG, Cheung A et al (2010) Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 55:1080–1090PubMedCrossRefGoogle Scholar
  174. 174.
    Thomas M, Schymik G, Walther T et al (2011) One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124:425–433PubMedCrossRefGoogle Scholar
  175. 175.
    Leon MB, Smith CR, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607PubMedCrossRefGoogle Scholar
  176. 176.
    Tay EL, Gurvitch R, Wijesinghe N et al (2011) A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc Interv 4:1290–1297PubMedCrossRefGoogle Scholar
  177. 177.
    Astarci P, Glineur D, Kefer J et al (2011) Magnetic resonance imaging evaluation of cerebral embolization during percutaneous aortic valve implantation: comparison of transfemoral and trans-apical approaches using Edwards Sapiens valve. Eur J Cardiothorac Surg 40:475–479PubMedGoogle Scholar
  178. 178.
    Kahlert P, Knipp SC, Schlamann M et al (2010) Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121:870–878PubMedCrossRefGoogle Scholar
  179. 179.
    Ghanem A, Muller A, Nahle CP et al (2010) Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J Am Coll Cardiol 55:1427–1432PubMedCrossRefGoogle Scholar
  180. 180.
    Rodes-Cabau J, Dumont E, Boone RH et al (2011) Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol 57:18–28PubMedCrossRefGoogle Scholar
  181. 181.
    Arnold M, Schulz-Heise S, Achenbach S et al (2010) Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging. JACC Cardiovasc Interv 3:1126–1132PubMedCrossRefGoogle Scholar
  182. 182.
    Fairbairn TA, Mather AN, Bijsterveld P et al (2012) Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98:18–23PubMedCrossRefGoogle Scholar
  183. 183.
    Drews T, Pasic M, Buz S et al (2011) Transcranial Doppler sound detection of cerebral microembolism during transapical aortic valve implantation. Thorac Cardiovasc Surg 59:237–242PubMedCrossRefGoogle Scholar
  184. 184.
    Etienne PY, Papadatos S, Pieters D et al (2011) Embol-x intraaortic filter and transaortic approach for improved cerebral protection in transcatheter aortic valve implantation. Ann Thorac Surg 92:e95–e96PubMedCrossRefGoogle Scholar
  185. 185.
    Nietlispach F, Wijesinghe N, Gurvitch R et al (2010) An embolic deflection device for aortic valve interventions. JACC Cardiovasc Interv 3:1133–1138PubMedCrossRefGoogle Scholar
  186. 186.
    Macdonald S (2011) New embolic protection devices: a review. J Cardiovasc Surg (Torino) 52:821–827Google Scholar
  187. 187.
    Tchetche D, Dumonteil N, Sauguet A et al (2010) Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 5:659–665PubMedCrossRefGoogle Scholar
  188. 188.
    Van Mieghem NM, Nuis RJ, Piazza N et al (2010) Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 5:673–679PubMedCrossRefGoogle Scholar
  189. 189.
    Ducrocq G, Francis F, Serfaty JM et al (2010) Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 5:666–672PubMedCrossRefGoogle Scholar
  190. 190.
    Kahlert P, Al-Rashid F, Weber M et al (2009) Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz 34:398–408PubMedCrossRefGoogle Scholar
  191. 191.
    Elhmidi Y, Bleiziffer S, Piazza N et al (2011) Incidence and predictors of acute kidney injury in patients undergoing transcatheter aortic valve implantation. Am Heart J 161:735–739PubMedCrossRefGoogle Scholar
  192. 192.
    Bagur R, Webb JG, Nietlispach F et al (2010) Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J 31:865–874PubMedCrossRefGoogle Scholar
  193. 193.
    Nuis RJ, Van Mieghem NM, Tzikas A et al (2011) Frequency, determinants, and prognostic effects of acute kidney injury and red blood cell transfusion in patients undergoing transcatheter aortic valve implantation. Catheter Cardiovasc Interv 77:881–889PubMedCrossRefGoogle Scholar
  194. 194.
    Sinning JM, Ghanem A, Steinhauser H et al (2010) Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 3:1141–1149PubMedCrossRefGoogle Scholar
  195. 195.
    Aregger F, Wenaweser P, Hellige GJ et al (2009) Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement. Nephrol Dial Transplant 24:2175–2179PubMedCrossRefGoogle Scholar
  196. 196.
    Tamburino C, Capodanno D, Ramondo A et al (2011) Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123:299–308PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Nicolo Piazza
    • 1
    • 2
  • Darren Mylotte
    • 1
  • Giuseppe Martucci
    • 1
  1. 1.Department of Interventional Cardiology at McGill University Health Center (MUHC)Royal Victoria HospitalMontrealCanada
  2. 2.Department of Cardiac Surgery at German Heart Center MunichMunichGermany

Personalised recommendations